Net sales are seen rising 9.26 percent YoY to Rs. 8,850 crore, according to the poll.
Earnings before interest, tax, depreciation, and amortisation are likely to increase 9.5 percent YoY to Rs. 1,900 crore.
Brokerage firms expect volume growth to be in the range of 6-8 percent. Hester Biosciences share price fell more than 3 percent on weak operational performance for March quarter.